Yunkang Group Limited (HKG:2325)

Market Cap	532.66M -85.2%
Revenue (ttm)	706.95M -18.8%
Net Income	-789.94M
EPS	-1.34
Shares Out	585.34M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	705,000
Average Volume	395,950
Open	0.9200
Previous Close	0.9200
Day's Range	0.9000 - 0.9200
52-Week Range	0.8800 - 5.7000
Beta	-0.69
RSI	41.23
Earnings Date	Mar 27, 2026

About Yunkang Group

Yunkang Group Limited operates as a medical operation service provider in the People's Republic of China. The company offers diagnostic testing services for medical institution alliances, including setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, procurement of equipment, smart internet of things, and logistics assistance. It also provides diagnostic outsourcing services comprising pathology tests; infectious disease diagnostic test...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2008
• Employees: 1,146
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2325

Financial Performance

In 2024, Yunkang Group's revenue was 711.88 million, a decrease of -20.15% compared to the previous year's 891.50 million. Losses were -791.68 million, 674.2% more than in 2023.

Financial numbers in CNY